51
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Association between Helicobacter pylori and Gastric Carcinoma in the City of Malmö, Sweden: A Prospective Study

, , &
Pages 1215-1221 | Received 12 May 1997, Accepted 22 Aug 1997, Published online: 08 Jul 2009

References

  • Parkin D. M., Läärä E., Muir C. S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184–97
  • Locke G. R I, Talley N. J., Carpenter H. A., Harmsen W. S., Zinsmeister A. R., Melton L. J I. Changes in the site-and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 1995; 109: 1750–6
  • Hoel D. G., Davis D. L., Miller A. B., Sondik E. J., Swcrdlow A. J. Trends in cancer mortality in 15 industrialized countries, 1969–1986. J Natl Cancer List 1992; 84: 313–20
  • Thomas R. M., Sobin L. H. Gastrointestinal cancer. Cancer 1995; 75(Suppl 1)154–70
  • Hansson L., Sparén P., Nyrén O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993; 80: 374–7
  • Neugut A. I., Hayek M., Howe G. Epidemiology of gastric cancer. Semin Oncol 1996; 23: 281–91
  • Hanszel W., Kurihara M., Segi M., Lee R. K C. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst 1972; 49: 969–88
  • Valle J., Kekki M., Sipponen P., Ihamäki T., Siurala M. Long-term course and consequences of Helicobacter pylori gastritis: results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31: 546–50
  • Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735–40
  • Cahill R. J., Kilgallen C., Beattie S., Hamilton H., O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996; 38: 177–81
  • Davies G. R., Simmonds N. J., Stevens T. R J, Sheaff M. T., Banatvala N., Laurenson I. F., et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179–85
  • Nguyen T., Brunson D., Crespi C. L., Penman B. W., Wishnok I. S., Tannenbaum S. R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992; 89: 3030–4
  • Sidebotham R. L., Batten J. J., Karim Q. N., Spencer J., Baron J. H. Breakdown of gastric mucus in presence of Helicobacter pylori. J Clin Pathol 1991; 44: 52–7
  • Banerjee S., Hawksby C., Miller S., Dahill S., Beattie A. D., McColl K. E. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317–22
  • Nomura A., Stemmermann G. N., Chyou P. H., Kato I., Perez P. C., Blaser M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6
  • Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
  • Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302–5
  • Hansen S., Vollset S. E., Melby K., Jellum E. Strong association of previous Helicobacter pylori infection to distal gastric adeno-carcinoma [abstract]. Am J Gastroenterol 1994; 89: 1358
  • Aromaa A., Kosunen T. U., Knekt P., Maatela J., Teppo L., Heinonen O. P., et al. Circulating anü-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen 1 level are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142–9
  • Lin J. T., Wang L. Y., Wang J. T., Wang T. H., Yang C. S., Chen C. J. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15: 603–6
  • Webb P. M., Yu M. C., Forman D., Henderson B. E., Newell D. G., Yuan J. M., et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603–7
  • Talley N. J., Zinsmeister A. R., Weaver A., DiMagno E. P., Carpenter H. A., Perez P. G., et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734–9
  • Sipponen P., Kosunen T. U., Valle J., Riihela M., Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45: 319–23
  • Kang J. C., Chung I. S. Helicobacter pylori infection and gastric adenocarcinoma in Korea: prevalence and distribution of Helicobacter pylori in resected specimen of gastric cancer. J Cathol Med Coll 1992; 45: 849–62
  • Hansson L. E., Engstrand L., Nyren O., Evans D. J., Lindgren A., Bergstrom R., et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098–103
  • Asaka M., Kimura T., Kato M., Kudo M., Miki K., Ogoshi K., et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994; 73: 2691–4
  • Kikuchi S., Wada O., Nakajima T., Nishi T., Kobayashi O., Konishi T., et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1995; 75: 2789–93
  • Blaser M. J., Kobayashi K., Cover T. L., Cao P., Feurer I. D., Perez P. G. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 1993; 55: 799–802
  • Lin J. T., Wang J. T., Wang T. H., Wu M. S., Lee T. K., Chen C. J. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan. Scand J Gastroenterol 1993; 28: 1067–72
  • Kuipers E. J., Gracia C. M., Pena A. S., Pals G., Van K. G., Kok A., et al. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993; 28: 433–7
  • Estevens J., Fidalgo P., Tendeiro T., Chagas C., Ferra A., Leitao C. N., et al. Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur J Cancer Prev 1993; 2: 377–80
  • Archimandritis A., Bitsikas J., Tjivras M., Anastasakou E., Tsavaris N., Kalogeras D., et al. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Ital J Gastroenterol 1993; 25: 368–71
  • Fukuda H., Saito D., Hayashi S., Hisai H., Ono H., Yoshida S., et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995; 86: 64–71
  • Forman D., Sitas F., Newell D. G., Stacey A. R., Boreham J., Peto R., et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608–11
  • An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993; 341: 1359–62
  • Correa P., Fox J., Fontham E., Ruiz B., Lin Y. P., Zavala D., et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569–74
  • Lin H.-Z. [Campylobacter pyloridis (Cp) infection of gastric mucosa in the high and low risk areas of gastric cancer in Liaoning province]. Chung Hua Chung Liu Tsa Chih 1989; 11: 365–7
  • International Agency of Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1–241
  • Berglund G., Eriksson K. F., Israelsson B., Kjellström T., Lindgärde F., Mattiasson I., et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 1996; 239: 489–97
  • The Swedish Cancer Registry. Cancer incidence in Sweden 1991. National Board of Health and Welfare, Stockholm 1994
  • Gnarpe H., Unge P., Blomqvist C., Makitalo S. Campylobacter pylori in Swedish patients referred for gastroscopy. Apmis 1988; 96: 128–32
  • Breslow N. E., Day N. E. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. IARC scientific publication no. 32, International Agency of Cancer Research, Lyon 1980
  • Hansson L. E., Nyrén O., Hsing A. W., Bergström R., Josefsson S., Chow W.-H., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. New Engl J Med 1996; 335: 242–9
  • Molloy R. M., Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut 1997; 40: 247–52
  • Tersmette A. C., Offerhaus J. A., Tersmette K. W F, Giardiello F. M., Moore G. W., Tytgat G. N J, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subset for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 1990; 50: 6486–9
  • Kuipers E. J., Thijs J. C., Festen H. P. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9(Suppl 2)59–69
  • Siurala M., Sipponen P., Kekki M. Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut 1988; 29: 909–15
  • Forman D., Webb P., Parsonnet J. H pylori and gastric cancer [letter]. Lancet 1994; 343: 243-A
  • Karnes W. J., Samloff I. M., Siurala M., Kekki M., Sipponen P., Kim S. W., et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167–74
  • Kuipers E. J., Uyterlinde A. M., Pena A. S., Roosendaal R., Pals G., Nelis G. F., et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525–8
  • Cutler A. F., Prasad V. M. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996; 91: 85–8
  • Sipponen P., Kosunen T. U., Samloff I. M., Heinonen O. P., Siurala M. Rate of Helicobacter pylori acquisition among Finnish adults: a 15-year follow-up. Scand J Gastroenterol 1996; 31: 229–32
  • Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev 1994; 3: 445–51
  • McCulloch P. Gastric cancer. Postgrad Med J 1996; 72: 450–7
  • Uemura N., Mukai T., Okamoto S., Yamaguchi S., Mashiba H., Taniyama K., et al. Helicobacter pylori eradication inhibits the growth of intestinal type of gastric cancer in initial stage [abstract]. Gastroenterology 1996; 110: A282
  • Pounder R. E., Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9(Suppl 2)33–9
  • Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.